Neurocrine Biosciences to present at three major healthcare investor conferences in September 2026

Neurocrine Biosciences announced that its executives will participate in three upcoming investor conferences in September 2026: Wells Fargo Healthcare Conference on September 9, Cantor Global Healthcare Conference on September 10, and Morgan Stanley Global Healthcare Conference on September 15. These events will feature fireside chats and will be webcast live on the company's website, with replays available for about a month. Neurocrine is a biopharmaceutical company focused on developing treatments for neurological, psychiatric, endocrine, and immunological disorders, with several FDA-approved therapies and a strong pipeline. This participation highlights the company's ongoing engagement with investors and its commitment to advancing its pipeline and market presence.